Cite
MLA Citation
T. Dhere et al.. “The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn's disease – a phase 1 trial with three doses.” Alimentary pharmacology & therapeutics, vol. 44, no. 5, 2016, pp. 471–481. http://access.bl.uk/ark:/81055/vdc_100035003937.0x000012